Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Director | September 18, 2026 | September 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date September 18, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 400 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Sale · Disposed 203 · Balance 400 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 18, 2026 18:51 UTC | Nutex Health Inc. NUTX · Entity 4803 | SaleCommon Stock | 203 | $214.25 | $43,492.75 |
DisclosureSEC source: 0002018971-26-000004 · primary_doc.xml · nonDerivative · entry 1 Saunders Scott J · CIK 0002018971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400 Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 14:04 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 603 | $0.00 | $0.00 |
DisclosureSEC source: 0002018971-26-000003 · primary_doc.xml · nonDerivative · entry 1 Saunders Scott J · CIK 0002018971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 18:32 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Units (RSUs) · Derivative | 823 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002018971-26-000002 · primary_doc.xml · derivative · entry 1 Saunders Scott J · CIK 0002018971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,426 Underlying: Common Stock · 823 shares Expires 2027-04-23 F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F1 · price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. F2 · derivative.expiration_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. Read SEC document |
| July 14, 2025 Filed Feb 9, 2026 18:04 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Units (RSUs) · Derivative | 603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002018971-26-000001 · primary_doc.xml · derivative · entry 1 Saunders Scott J · CIK 0002018971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 603 Underlying: Common Stock · 603 shares Expires 2026-07-14 F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. F2 · derivative.expiration_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.